Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Júlia Koller

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Plos One|April 7, 2020
Modified linear regression predicts drug-target interactions accuratelyKrisztian Buza, Ladislav Peška, Júlia Koller
Computer Methods and Programs in Biomedicine|October 22, 2017
Drug-target interaction prediction: A Bayesian ranking approachLadislav Peska, Krisztian Buza, Júlia Koller
Ideggyogyaszati Szemle|June 6, 2018
[Multilocus genetic analysis implicates neurodevelopment and immune system in the etiology of schizophrenia]Attila József Pulay, Júlia Koller, László Nagy, et al.
European Child & Adolescent Psychiatry|November 8, 2024
Electrophysiological indices of reward anticipation as ADHD risk and prognostic biomarkersNóra Bunford, Kristóf Ágrez, György Hámori, et al.
Database : the Journal of Biological Databases and Curation|January 17, 2020
ChIPSummitDB: a ChIP-seq-based database of human transcription factor binding sites and the topological arrangements of the proteins bound to themErik Czipa, Mátyás Schiller, Tibor Nagy, et al.
Schizophrenia Research|January 30, 2024
Probing the biological consequences of a previously undescribed de novo mutation of ZMYND11 in a schizophrenia patient by CRISPR genome editing and induced pluripotent stem cell based in vitro disease-modelingCsongor Tordai, Edit Hathy, Hella Gyergyák, et al.
Stem Cell Research & Therapy|November 28, 2020
Investigation of de novo mutations in a schizophrenia case-parent trio by induced pluripotent stem cell-based in vitro disease modeling: convergence of schizophrenia- and autism-related cellular phenotypesEdit Hathy, Eszter Szabó, Nóra Varga, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Plos One|April 7, 2020
Modified linear regression predicts drug-target interactions accuratelyKrisztian Buza, Ladislav Peška, Júlia Koller
Computer Methods and Programs in Biomedicine|October 22, 2017
Drug-target interaction prediction: A Bayesian ranking approachLadislav Peska, Krisztian Buza, Júlia Koller
Ideggyogyaszati Szemle|June 6, 2018
[Multilocus genetic analysis implicates neurodevelopment and immune system in the etiology of schizophrenia]Attila József Pulay, Júlia Koller, László Nagy, et al.
European Child & Adolescent Psychiatry|November 8, 2024
Electrophysiological indices of reward anticipation as ADHD risk and prognostic biomarkersNóra Bunford, Kristóf Ágrez, György Hámori, et al.
Database : the Journal of Biological Databases and Curation|January 17, 2020
ChIPSummitDB: a ChIP-seq-based database of human transcription factor binding sites and the topological arrangements of the proteins bound to themErik Czipa, Mátyás Schiller, Tibor Nagy, et al.
Schizophrenia Research|January 30, 2024
Probing the biological consequences of a previously undescribed de novo mutation of ZMYND11 in a schizophrenia patient by CRISPR genome editing and induced pluripotent stem cell based in vitro disease-modelingCsongor Tordai, Edit Hathy, Hella Gyergyák, et al.
Stem Cell Research & Therapy|November 28, 2020
Investigation of de novo mutations in a schizophrenia case-parent trio by induced pluripotent stem cell-based in vitro disease modeling: convergence of schizophrenia- and autism-related cellular phenotypesEdit Hathy, Eszter Szabó, Nóra Varga, et al.
Pageof 1